US-Irish firm Medtronic (NYSE: MDT) has inaugurated its digital medical innovation base at the BioPark in Beijing, marking the company’s first such facility in China. This strategic move underscores Medtronic’s commitment to leveraging advanced technologies in the Chinese healthcare sector.
Facility Details and Focus
The new base will concentrate on developing disease management solutions through artificial intelligence and big data. It will house a medical training center covering cardiovascular, minimally invasive surgery, and neuroscience disciplines. Additionally, a patient care center will be established to integrate digital technology, enhancing patient prevention and management services. The facility will also include the Medtronic Museum, showcasing the company’s contributions to healthcare innovation.
Operational Timeline and Impact
The digital medical innovation base is expected to become fully operational by the end of this year. This development aligns with China’s growing focus on digital healthcare solutions and positions Medtronic as a key player in advancing medical technology within the region.-Fineline Info & Tech
Leave a Reply